{"transactions":[{"id":751229,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T23:47:11.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":11050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 11,050 of the Issuer's ordinary shares and vests in full on the earlier of (i) June 2, 2027 or (ii) the date of the Issuer's next annual meeting of shareholders, in each case, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":11050,"derivative":{"exercise_price":17.01,"expiration_date":"2036-06-02","underlying":"Ordinary Shares","underlying_shares":11050},"source":{"system":"sec-edgar","filing":"0001628280-26-040577","document":"wk-form4_1780530428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000162828026040577/wk-form4_1780530428.xml","form_type":"4"}},{"id":757227,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-01T20:30:11.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":13160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 28, 2026, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":13160,"derivative":{"exercise_price":32.68,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":13160},"source":{"system":"sec-edgar","filing":"0001193125-26-251538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526251538/ownership.xml","form_type":"4"}},{"id":1103560,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T22:51:54.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":9023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of the Issuer's ordinary shares and vests in full on the earlier of (i) June 23, 2026 or (ii) the date of the Issuer's next annual meeting of shareholders, in each case, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":9023,"derivative":{"exercise_price":15.3,"expiration_date":"2035-06-23","underlying":"Ordinary Shares","underlying_shares":9023},"source":{"system":"sec-edgar","filing":"0001104659-25-061820","document":"tm2518376-18_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000110465925061820/tm2518376-18_4seq1.xml","form_type":"4"}},{"id":1105858,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T23:45:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026,  or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":52307,"source":{"system":"sec-edgar","filing":"0000950170-25-088065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826892/000095017025088065/ownership.xml","form_type":"4"}},{"id":1127827,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:05:07.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":22200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 29, 2025, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":22200,"derivative":{"exercise_price":9.25,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":22200},"source":{"system":"sec-edgar","filing":"0000950170-25-080228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025080228/ownership.xml","form_type":"4"}},{"id":1478358,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:13:10.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":28807,"source":{"system":"sec-edgar","filing":"0000950170-24-073659","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826892/000095017024073659/ownership.xml","form_type":"4"}},{"id":1522209,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-05-09T20:49:36.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":37200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares of common stock subject to the option vest monthly following May 7, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":37200,"derivative":{"exercise_price":17.94,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":37200},"source":{"system":"sec-edgar","filing":"0000950170-24-057201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024057201/ownership.xml","form_type":"4"}},{"id":1614377,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-27T16:45:01.000Z","date":"2024-02-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":164000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":22.72,"expiration_date":"2033-11-16","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001415889-24-005507","document":"form4-02272024_090249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924005507/form4-02272024_090249.xml","form_type":"4"}},{"id":1614376,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-27T16:45:01.000Z","date":"2024-02-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":194514,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.24,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":194514},"source":{"system":"sec-edgar","filing":"0001415889-24-005507","document":"form4-02272024_090249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924005507/form4-02272024_090249.xml","form_type":"4"}},{"id":1614375,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-27T16:45:01.000Z","date":"2024-02-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":77805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.24,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":77805},"source":{"system":"sec-edgar","filing":"0001415889-24-005507","document":"form4-02272024_090249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924005507/form4-02272024_090249.xml","form_type":"4"}},{"id":1614374,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-27T16:45:01.000Z","date":"2024-02-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60757,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $62.50 per Share over (y) the exercise price payable per Share under such option, which amount will be subject to any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.24,"expiration_date":"2031-09-28","underlying":"Common Stock","underlying_shares":60757},"source":{"system":"sec-edgar","filing":"0001415889-24-005507","document":"form4-02272024_090249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924005507/form4-02272024_090249.xml","form_type":"4"}},{"id":1614373,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T16:45:01.000Z","date":"2024-02-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":323455,"price":62.5,"value":20215937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 25, 2023, by and among RayzeBio, Inc. (the \"Issuer\"), Bristol-Myers Squibb Company (\"BMS\") and, by way of a joinder dated December 26, 2023, Rudolph Merger Sub Inc., a wholly owned subsidiary of BMS (\"Purchaser\"), on February 22, 2024, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of BMS (the \"Merger\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the $62.50 per Share in cash, without interest, subject to any applicable withholding of taxes (the \"Cash Amount\").  At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for the Cash Amount."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 808 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on February 22, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-005507","document":"form4-02272024_090249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924005507/form4-02272024_090249.xml","form_type":"4"}},{"id":1656384,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-06T18:11:00.000Z","date":"2024-01-22","kind":"exercise","planned":false,"acquired":false,"shares":30875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on September 29, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":60757,"derivative":{"exercise_price":3.24,"expiration_date":"2031-09-28","underlying":"Common Stock","underlying_shares":30875},"source":{"system":"sec-edgar","filing":"0001415889-24-002852","document":"form4-02062024_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924002852/form4-02062024_110254.xml","form_type":"4"}},{"id":1656383,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-06T18:11:00.000Z","date":"2024-01-22","kind":"exercise","planned":false,"acquired":true,"shares":30875,"price":3.24,"value":100035.0,"ownership":{"direct":true},"balance_after":322647,"source":{"system":"sec-edgar","filing":"0001415889-24-002852","document":"form4-02062024_110254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000141588924002852/form4-02062024_110254.xml","form_type":"4"}},{"id":1735915,"issuer":{"id":93779,"kind":"organization","name":"RayzeBio, Inc.","symbol":"RYZB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-17T18:36:13.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant."}],"balance_after":164000,"derivative":{"exercise_price":22.72,"expiration_date":"2033-11-16","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001628280-23-039535","document":"wk-form4_1700264163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825367/000162828023039535/wk-form4_1700264163.xml","form_type":"4"}},{"id":1853726,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:41:04.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-037547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826892/000120919123037547/doc4.xml","form_type":"4"}},{"id":2226406,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T23:51:38.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-038170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826892/000120919122038170/doc4.xml","form_type":"4"}},{"id":2665392,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":41672,"kind":"person","name":"Moran Susan","position":1,"cik":"0001835225","reported_name":"Moran Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T01:34:07.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":12307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months."}],"balance_after":12307,"derivative":{"exercise_price":39.64,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":12307},"source":{"system":"sec-edgar","filing":"0001209191-21-041227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826892/000120919121041227/doc4.xml","form_type":"4"}}]}